CEWG January 09 Full Report - National Institute on Drug Abuse

More documents

Recommendations

Info

Contents Benzodiazepines/Depressants..................................................................................................................................... 87 Methamphetamine .......................................................................................................................................................... 89 Marijuana/Cannabis......................................................................................................................................................... 92 Club Drugs (MDMA, GHB/GBL, LSD, and Ketamine)............................................................................................. 95 Phencyclidine (PCP) ......................................................................................................................................................... 96 Other Drugs (BZP, TFMPP, Foxy Methoxy, and Carisoprodol)............................................................................ 98 Appendix Tables ..................................................................................................................................99 Appendix Table 1. Total Treatment Admissions by Primary Substance of Abuse, Including Primary Alcohol Admissions, and <strong>CEWG</strong> Area: FY 2008 and <strong>January</strong>–June 2008...................................... 99 Appendix Tables 2.1–2.22. NFLIS Top 10 Most Frequently Identified Drugs of Total Analyzed Drug Items in Forensic Laboratories for 22 <strong>CEWG</strong> Areas: <strong>January</strong>–June 2008...........100 Appendix Table 3.1. DAWN ED Samples and <strong>Report</strong>ing Information, by <strong>CEWG</strong> Area: <strong>January</strong>–June 2008.........................................................................................................................................................106 Appendix Table 3.2. Number of Cocaine, Heroin, Methamphetamine (MA), Marijuana (MJ), Methylenedioxymethamphetamine (MDMA), Phencyclidine (PCP), and Lysergic Acid Diethylamide (LSD) ED <strong>Report</strong>s in 11 <strong>CEWG</strong> Areas (Unweighted): <strong>January</strong>–June 2008........................107 Participant List...................................................................................................................................1<strong>09</strong> Proceedings of the Community Epidemiology Work Group, <strong>January</strong> 20<strong>09</strong> v
Foreword Foreword This Executive Summary provides a synthesis of findings from reports presented and data prepared for the 65th semiannual meeting of the <strong>National</strong> <strong>Institute</strong> on Drug Abuse (NIDA) Community Epidemiology Work Group (<strong>CEWG</strong>) held in San Francisco, California, on <strong>January</strong> 21–23, 20<strong>09</strong>. The <strong>CEWG</strong> is a network of researchers from sentinel sites throughout the United States. It meets semiannually to provide ongoing community-level public health surveillance of drug abuse through presentation and discussion of quantitative and qualitative data. <strong>CEWG</strong> representatives access multiple sources of existing data from their local areas to report on drug abuse patterns and consequences in their areas and to provide an alert to potentially emerging new issues. Local area data are supplemented, as possible, with data available from federally-supported projects, such as the Substance Abuse and Mental Health Services Administration (SAMHSA) Drug Abuse Warning Network (DAWN), Drug Enforcement Administration (DEA) <strong>National</strong> Forensic Laboratory Information System (NFLIS), and the DEA Heroin Domestic Monitor Program (HDMP). This descriptive and analytic information is used to inform the health and scientific communities and the general public about the current nature and patterns of drug abuse, emerging trends, and consequences of drug abuse. The <strong>CEWG</strong> convenes twice yearly, in <strong>January</strong> and June. For the June meetings, <strong>CEWG</strong> representatives prepare full reports on drug abuse patterns and trends in their areas. After the meeting, a Highlights and Executive Summary <strong>Report</strong> is produced, and the full <strong>CEWG</strong> area reports are included in a second volume. For the <strong>January</strong> report, the representatives present an abbreviated report to provide an update on data newly available since the prior June report and to identify significant issues which have emerged since the prior meeting. These abbreviated reports, or Update Briefs, are included in this Executive Summary <strong>Report</strong>, along with highlights from the meeting and cross-site data compilations. A second volume is no longer produced for the <strong>January</strong> meetings. For the <strong>January</strong> 20<strong>09</strong> meeting, <strong>CEWG</strong> representatives were invited to provide an overview and update on drug abuse trends in their areas, with particular attention to issues pertaining to the abuse of heroin and prescription opiates. In addition, representatives from border States, Mexico, and Canada were invited to briefly address drug abuse issues along the United States northern and southern borders. After the area reports, breakout groups were formed to discuss key drug abuse indicators and to review meeting findings by region. Other highlights of the meeting included: a presentation by DEA representative Scott Rowan on heroin traffcking in the United States; a workshop on prescription drugs provided by Jan Scaglione, Pharm. D.; a session on geographic information system approaches to drug abuse research by Yonette Thomas, Ph.D., Ilene Anderson, Pharm. D., and Rudy Banerjee, Ph.D.; a report on the <strong>National</strong> Drug Intelligence Center Sentry Program by Susan Seese; and presentations on NIDA-supported research in the San Francisco area. The NIDA-supported research presentations related to: club drug use among Asian American youth and young adults, presented by Geoffrey Hunt, Ph.D.; prescription drug abuse, presented by Sheigla Murphy, Ph.D.; and heroin-related research and methamphetamine use among women, presented by Alexander Kral, Ph.D. and Jennifer Lorvick, M.P.H. The present report includes the <strong>CEWG</strong> Update Briefs and International <strong>Report</strong>s, and highlights findings from the <strong>CEWG</strong> area reports and discussions. Moira P. O’Brien Division of Epidemiology, Services and Prevention Research <strong>National</strong> <strong>Institute</strong> on Drug Abuse <strong>National</strong> <strong>Institute</strong>s of Health Department of Health and Human Services Proceedings of the Community Epidemiology Work Group, <strong>January</strong> 20<strong>09</strong> vii
Page 1 and 2: EpidEmiologic TrEnds in drug AbusE
Page 3 and 4: EpidEmiologic TrEnds in drug AbusE:
Page 5: EpidEmiologic TrEnds in drug AbusE:
Page 35 and 36: 58.9 17.5 1.8 1.5 EpidEmiologic TrE
Page 57 and 58:
EpidEmiologic TrEnds in drug AbusE:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Participant List Participant List <
Page 117 and 118:
Participant List Daniel P. Dooley S
Page 119 and 120:
Participant List John A. Newmeyer,
Page 121:
NIH Publication No. 09</str
show all

CEWG January 09 Full Report - National Institute on Drug Abuse

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?